Document is current
Any future updates will be listed below
-
Authors
Lent, Maria C.
Cerutti, Janine
Reblin, Maija
Holcombe, Randall F.
-
Funding
Funding for this research was provided by:
University of Vermont Cancer Center
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 30 October 2025
First Online: 19 November 2025
Declarations
:
: All patients had been enrolled on a clinical trial and completed written informed consent as approved by the University of Vermont Institutional Review Board for the individual trial. This follow-up study was implemented as a quality improvement project. It was reviewed by the University of Vermont Institutional Review Board and the IRB determined that additional informed consent was not required. The IRB reviewed the text of the information being provided to participants and deemed that agreement to answer the interview questions was patient assent and was sufficient.
: Not applicable. All quotes were anonymized.
: The views expressed in the submitted article are the authors’ own and not an official position of the University of Vermont Cancer Center.
: The authors declare no competing interests.
